HOME › DRUGS › RETIFANLIMAB-DLWR
ACTIVE SUBSTANCE / INN

RETIFANLIMAB-DLWR

Brand name(s): ZYNYZ
FDA LISTED
PRESCRIPTION
BLA761334
ACTIVE SUBSTANCE
Retifanlimab-Dlwr
REGULATORS
FDA
SPONSORS / MAH
INCYTE CORP
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ZYNYZBLA761334INCYTE CORPPrescription

FULL INTELLIGENCE ON RETIFANLIMAB-DLWR

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →